Free Trial
→ Do NOT Buy SpaceX – Do This Instead (From Stansberry Research) (Ad)tc pixel Free CDXS Stock Alerts

Codexis (CDXS) Financials

Codexis logo
$1.36 -0.05 (-3.55%)
As of 10/8/2026 04:00 PM Eastern
Compare
Annual Income Statements for Codexis

Annual Income Statements for Codexis

This table shows Codexis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -19 -7.58 -8.56 -23 -11 -12 -24 -21 -34 -76 -65
Consolidated Net Income / (Loss)		 -19 -7.58 -8.56 -23 -11 -12 -24 -21 -34 -76 -65
Net Income / (Loss) Continuing Operations		 -19 -7.58 -8.56 -23 -11 -12 -24 -21 -34 -76 -65
Total Pre-Tax Income 		-19 -7.92 -8.60 -23 -11 -12 -24 -21 -33 -76 -65
Total Operating Income		 -19 -7.77 -8.56 -23 -11 -13 -24 -23 -35 -68 -59
Total Gross Profit		 26 35 39 36 48 53 55 83 101 57 43
Total Revenue		 35 42 49 50 61 68 69 105 139 70 59
Operating Revenue		 35 42 49 50 61 68 69 105 139 70 59
Total Cost of Revenue		 9.73 6.59 9.75 14 13 16 14 22 38 13 16
Operating Cost of Revenue		 9.73 6.59 9.75 14 13 16 14 22 38 13 16
Total Operating Expenses		 45 43 48 59 59 65 79 105 135 125 102
Selling, General & Admin Expense		 22 22 25 29 29 32 35 49 52 53 55
Research & Development Expense		 23 21 22 30 30 34 44 56 80 59 46
Impairment Charge		 - - - - - - - 0.00 0.00 9.98 0.17
Restructuring Charge		 - - - - - - 0.00 0.00 3.17 3.28 0.00
Total Other Income / (Expense), net		 -0.22 -0.15 -0.03 0.06 0.38 0.63 0.25 1.61 1.57 -8.10 -6.72
Interest & Investment Income		 0.02 0.02 0.06 0.15 0.67 1.29 0.41 0.46 1.44 4.17 3.67
Other Income / (Expense), net		 -0.23 -0.17 -0.09 -0.09 -0.29 -0.66 -0.16 1.15 0.12 -12 -10
Income Tax Expense		 -0.26 -0.34 -0.04 0.08 -0.04 0.02 0.34 0.19 0.28 0.07 0.03
Basic Earnings per Share		 ($0.50) ($0.19) ($0.21) ($0.50) ($0.21) ($0.21) ($0.40) ($0.33) ($0.51) ($1.12) ($0.89)
Weighted Average Basic Shares Outstanding		 38.21M 39.44M 40.63M 46.23M 52.21M 56.53M 59.36M 64.57M 65.34M 68.13M 73.41M
Diluted Earnings per Share		 ($0.50) ($0.19) ($0.21) ($0.50) ($0.21) ($0.21) ($0.40) ($0.33) ($0.51) ($1.12) ($0.89)
Weighted Average Diluted Shares Outstanding		 38.21M 39.44M 40.63M 46.23M 52.21M 56.53M 59.36M 64.57M 65.34M 68.13M 73.41M
Weighted Average Basic & Diluted Shares Outstanding		 38.21M 39.44M 40.63M 46.23M 52.21M 56.53M 59.36M 65.16M 65.95M 70.30M 82.84M

Quarterly Income Statements for Codexis

This table shows Codexis' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -35 -7.19 -12 -23 -21 -10 -21 -13 -20 -8.70 -12
Consolidated Net Income / (Loss)		 -35 -7.19 -12 -23 -21 -10 -21 -13 -20 -8.70 -12
Net Income / (Loss) Continuing Operations		 -35 -7.19 -12 -23 -21 -10 -21 -13 -20 -8.70 -12
Total Pre-Tax Income 		-35 -7.16 -11 -23 -21 -10 -21 -13 -20 -8.67 -12
Total Operating Income		 -32 0.28 -12 -23 -17 -7.34 -20 -13 -19 -8.04 -11
Total Gross Profit		 7.03 24 12 4.52 8.52 18 4.81 13 6.14 13 11
Total Revenue		 9.28 27 17 7.98 13 21 7.54 15 8.60 15 15
Operating Revenue		 9.28 27 17 7.98 13 21 7.54 15 8.60 15 15
Total Cost of Revenue		 2.25 2.86 4.86 3.46 4.32 3.65 2.73 2.10 2.47 2.06 3.51
Operating Cost of Revenue		 2.25 2.86 4.86 3.46 4.32 3.65 2.73 2.10 2.47 2.06 3.51
Total Operating Expenses		 39 23 24 27 25 25 25 26 25 21 23
Selling, General & Admin Expense		 12 12 13 16 14 13 12 12 11 9.78 11
Research & Development Expense		 14 11 11 11 12 12 13 14 14 11 12
Total Other Income / (Expense), net		 -2.84 -7.44 0.39 -0.01 -4.07 -3.03 -0.19 -0.40 -0.66 -0.63 -0.77
Interest & Investment Income		 1.06 0.91 0.91 0.97 0.85 0.94 0.75 0.58 0.63 0.67 0.54
Other Income / (Expense), net		 -3.90 -8.35 -0.52 -0.99 -4.92 -3.97 -0.94 -0.98 -1.29 -1.29 -1.30
Income Tax Expense		 0.01 0.04 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.04 0.01
Basic Earnings per Share		 ($0.50) ($0.11) ($0.16) ($0.32) ($0.29) ($0.12) ($0.25) ($0.16) ($0.22) ($0.10) ($0.13)
Weighted Average Basic Shares Outstanding		 69.47M 68.13M 69.85M 70.38M 72.03M 73.41M 82.41M 85.39M 90.25M 90.77M 91.05M
Diluted Earnings per Share		 ($0.50) ($0.11) ($0.16) ($0.32) ($0.29) ($0.12) ($0.25) ($0.16) ($0.22) ($0.10) ($0.13)
Weighted Average Diluted Shares Outstanding		 69.47M 68.13M 69.85M 70.38M 72.03M 73.41M 82.41M 85.39M 90.25M 90.77M 91.05M
Weighted Average Basic & Diluted Shares Outstanding		 - 70.30M 70.56M 70.93M 81.38M 82.84M 82.84M 90.27M 90.32M 90.90M 109.51M

Annual Cash Flow Statements for Codexis

This table details how cash moves in and out of Codexis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 4.36 -3.21 -3.20 12 22 38 59 -32 -2.87 -49 -46
Net Cash From Operating Activities		 0.32 -0.43 -1.86 -8.76 -14 -13 -16 -14 11 -53 -49
Net Cash From Continuing Operating Activities		 0.32 -0.43 -1.86 -8.76 -14 -13 -16 -14 11 -53 -49
Net Income / (Loss) Continuing Operations		 -19 -7.58 -8.56 -23 -11 -12 -24 -21 -34 -76 -65
Consolidated Net Income / (Loss)		 -19 -7.58 -8.56 -23 -11 -12 -24 -21 -34 -76 -65
Depreciation Expense		 3.31 2.04 1.73 1.04 1.15 1.57 1.95 3.11 5.40 5.52 4.95
Amortization Expense		 3.38 3.37 2.81 0.00 0.00 2.99 2.60 2.83 0.00 0.00 -0.50
Non-Cash Adjustments To Reconcile Net Income		 5.81 4.84 5.63 6.54 7.98 7.47 6.88 8.71 18 36 23
Changes in Operating Assets and Liabilities, net		 6.89 -3.11 -3.48 6.66 -12 -13 -3.89 -7.64 22 -18 -12
Net Cash From Investing Activities		 4.65 -1.26 -0.85 -0.98 -2.77 -3.67 -5.75 -21 -14 -4.86 -57
Net Cash From Continuing Investing Activities		 4.65 -1.26 -0.85 -0.98 -2.77 -3.67 -5.75 -21 -14 -4.86 -57
Purchase of Property, Plant & Equipment		 -0.30 -1.20 -0.89 -0.99 -2.77 -3.73 -3.75 -14 -8.31 -4.42 -4.31
Purchase of Investments		 - - - - 0.00 0.00 -2.00 -7.63 -5.30 -1.19 -90
Sale of Property, Plant & Equipment		 0.17 0.02 0.04 0.00 0.00 0.00 0.00 0.04 0.03 0.75 0.09
Sale and/or Maturity of Investments		 3.00 - - 0.00 0.00 0.06 - - 0.00 0.00 37
Net Cash From Financing Activities		 -0.61 -1.52 -0.49 22 39 54 81 3.77 -0.58 8.17 61
Net Cash From Continuing Financing Activities		 -0.61 -1.52 -0.49 22 39 54 81 3.77 -0.58 8.17 61
Repayment of Debt		 - 0.00 0.00 -0.18 - -0.24 -0.06 -0.21 -0.04 -0.50 -0.64
Issuance of Debt		 - - - - - - - - 0.00 0.00 30
Issuance of Common Equity		 0.01 0.00 0.00 24 37 50 86 0.00 0.00 8.65 32
Other Financing Activities, net		 -0.62 -1.52 -0.49 -1.40 1.25 4.25 0.07 3.97 -0.53 0.02 -0.32
Cash Interest Paid		 - 0.00 0.01 0.14 0.08 0.05 0.05 0.01 0.03 0.04 2.57
Cash Income Taxes Paid		 0.02 0.01 0.01 0.03 0.01 0.01 0.31 0.10 0.10 0.19 0.02

Quarterly Cash Flow Statements for Codexis

This table details how cash moves in and out of Codexis' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -9.93 -7.07 -39 19 -18 -0.94 8.44 -1.43 -14 -12
Net Cash From Operating Activities		 -11 -7.79 -12 -13 -16 -14 -18 -7.70 -13 -9.64
Net Cash From Continuing Operating Activities		 -11 -7.79 -12 -13 -16 -14 -18 -7.70 -13 -13
Net Income / (Loss) Continuing Operations		 -7.19 -12 -23 -21 -10 -21 -13 -20 -8.70 -12
Consolidated Net Income / (Loss)		 -7.19 -12 -23 -21 -10 -21 -13 -20 -8.70 -12
Depreciation Expense		 1.22 1.25 1.26 1.22 1.21 1.20 1.34 1.36 1.29 1.21
Amortization Expense		 - 0.04 -0.18 -0.26 -0.10 -0.05 0.02 0.02 0.14 0.16
Non-Cash Adjustments To Reconcile Net Income		 11 3.94 5.64 7.42 6.44 2.98 3.26 3.25 2.36 -0.37
Changes in Operating Assets and Liabilities, net		 -16 -1.52 3.87 -0.73 -14 2.76 -9.32 7.28 -8.23 -1.54
Net Cash From Investing Activities		 1.10 -29 -27 1.53 -2.86 12 -0.37 6.39 -1.11 0.18
Net Cash From Continuing Investing Activities		 1.10 -29 -27 1.53 -2.86 12 -0.37 6.39 -1.11 0.18
Purchase of Property, Plant & Equipment		 0.38 -1.13 -0.40 -1.01 -1.77 -1.26 -2.51 -0.18 -0.18 -0.90
Purchase of Investments		 - -27 -30 -16 -18 -10 -14 -18 -20 -13
Sale and/or Maturity of Investments		 - 0.00 3.00 18 17 23 16 24 19 14
Net Cash From Financing Activities		 - 29 -0.20 30 1.13 1.09 27 -0.11 -0.01 0.07
Net Cash From Continuing Financing Activities		 - 29 -0.20 30 1.13 1.09 27 -0.11 -0.01 0.07
Repayment of Debt		 - -0.46 -0.18 -1.62 - -0.01 0.01 - -0.01 0.01
Other Financing Activities, net		 - 0.22 -0.34 0.40 1.01 1.10 -0.72 -0.11 0.00 -0.10
Cash Interest Paid		 0.02 0.15 0.74 0.74 0.93 0.43 0.91 0.90 0.89 0.61

Annual Balance Sheets for Codexis

This table presents Codexis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 45 36 54 79 149 222 246 250 137 149 148
Total Current Assets		 33 27 45 68 114 184 162 163 93 99 97
Cash & Equivalents		 23 19 31 53 90 149 117 114 65 19 51
Restricted Cash		 - - - 0.00 0.66 0.64 - 0.52 0.52 0.50 0.48
Short-Term Investments		 - - - - - 1.00 - - 0.00 54 27
Note & Lease Receivable		 - - - - 20 29 38 41 20 19 11
Accounts Receivable		 7.33 5.92 12 13 20 29 38 32 9.14 2.75 1.48
Inventories, net		 0.99 0.83 1.04 0.59 0.37 0.96 1.16 2.03 2.69 1.80 1.82
Prepaid Expenses		 1.25 1.24 0.98 1.07 2.52 3.42 5.70 5.49 5.22 4.13 5.63
Plant, Property, & Equipment, net		 3.11 2.16 2.82 4.76 6.28 9.68 21 23 15 14 13
Total Noncurrent Assets		 8.70 6.23 5.77 6.33 29 28 49 65 18 33 35
Goodwill		 3.24 3.20 3.24 3.24 3.24 3.24 3.24 3.24 2.46 2.46 2.46
Other Noncurrent Operating Assets		 0.31 0.26 1.86 2.50 25 23 46 41 14 30 31
Other Noncurrent Nonoperating Assets		 - - - - - - - - 1.06 1.06 1.61
Total Liabilities & Shareholders' Equity		 45 36 54 79 149 222 246 250 137 149 148
Total Liabilities		 22 17 29 23 44 52 82 106 50 82 97
Total Current Liabilities		 15 12 25 18 15 25 33 49 36 24 25
Short-Term Debt		 - - - - 0.06 - - - 3.78 2.83 2.94
Accounts Payable		 3.40 4.23 3.55 3.05 2.62 2.97 3.00 3.25 5.95 2.84 1.55
Accrued Expenses		 2.01 2.11 4.36 4.86 6.54 10 13 15 4.74 6.22 2.77
Current Deferred Revenue		 6.10 1.71 12 4.94 0.06 1.82 2.59 5.36 10 0.35 7.01
Current Employee Benefit Liabilities		 3.33 4.31 4.75 5.27 5.00 7.29 11 11 11 11 11
Total Noncurrent Liabilities		 6.93 4.18 4.13 4.86 28 27 49 57 14 58 72
Long-Term Debt		 - 0.00 - - 0.03 0.07 - 0.16 0.00 29 40
Capital Lease Obligations		 1.31 0.89 0.76 0.10 25 22 - 38 12 28 30
Noncurrent Deferred Revenue		 3.12 1.07 1.50 3.35 1.99 2.97 3.75 17 0.64 0.10 0.36
Other Noncurrent Operating Liabilities		 2.50 2.23 1.86 1.42 1.23 1.27 45 1.37 1.23 1.27 1.33
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 23 19 25 56 106 170 164 145 87 67 51
Total Preferred & Common Equity		 23 19 25 56 106 170 164 145 87 67 51
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 23 19 25 56 106 170 164 145 87 67 51
Common Stock		 306 311 340 387 448 537 552 566 584 630 657
Retained Earnings		 -284 -292 -315 -330 -342 -366 -388 -421 -498 -563 -607
Accumulated Other Comprehensive Income / (Loss)		 0.41 0.00 -0.47 - - - - - 0.00 0.05 0.01

Quarterly Balance Sheets for Codexis

This table presents Codexis' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 154 150 132 148 129 138 124 129 120
Total Current Assets		 103 108 91 113 78 89 76 80 72
Cash & Equivalents		 75 58 19 37 18 27 25 37 27
Restricted Cash		 0.99 0.52 0.52 0.51 0.50 0.50 0.49 0.43 0.42
Short-Term Investments		 - 27 55 53 41 40 33 29 28
Note & Lease Receivable		 19 14 12 17 12 16 9.73 8.03 12
Accounts Receivable		 5.66 5.46 4.38 3.46 3.41 2.98 1.62 0.85 0.81
Inventories, net		 2.31 2.44 2.23 2.10 1.78 1.95 1.94 2.00 1.60
Prepaid Expenses		 5.40 5.27 3.06 3.49 4.16 3.47 5.34 4.06 3.33
Plant, Property, & Equipment, net		 15 15 14 13 16 15 14 13 12
Total Noncurrent Assets		 36 27 27 22 32 32 31 37 36
Long-Term Investments		 18 9.70 9.70 5.79 - - - 2.50 2.50
Goodwill		 2.46 2.46 2.46 2.46 2.46 2.46 2.46 2.46 2.46
Other Noncurrent Operating Assets		 15 14 13 13 29 28 27 31 30
Other Noncurrent Nonoperating Assets		 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.61 1.61
Total Liabilities & Shareholders' Equity		 154 150 132 148 129 138 124 129 120
Total Liabilities		 63 70 71 75 79 83 85 86 87
Total Current Liabilities		 38 29 31 35 21 15 18 15 24
Short-Term Debt		 6.76 3.88 3.98 4.08 2.91 3.00 3.09 3.30 10
Accounts Payable		 3.10 3.47 3.69 4.21 6.05 1.47 2.43 2.13 2.61
Accrued Expenses		 8.80 5.37 5.42 6.51 5.12 3.41 2.99 3.20 3.37
Current Deferred Revenue		 9.24 9.86 9.80 10 0.44 0.10 0.30 0.87 0.86
Current Employee Benefit Liabilities		 11 6.50 7.66 10 6.39 7.26 9.68 5.36 6.32
Total Noncurrent Liabilities		 25 41 40 40 58 67 67 71 64
Long-Term Debt		 0.13 28 28 29 29 39 40 41 34
Capital Lease Obligations		 13 11 10 9.13 27 27 26 29 28
Noncurrent Deferred Revenue		 10 0.63 0.20 0.61 0.49 0.10 0.10 0.35 0.00
Other Noncurrent Operating Liabilities		 1.22 1.25 1.26 1.28 1.28 1.30 1.31 1.34 1.35
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 92 79 61 73 50 56 39 43 33
Total Preferred & Common Equity		 92 79 61 73 50 56 39 43 33
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 92 79 61 73 50 56 39 43 33
Common Stock		 582 588 593 626 633 652 655 659 660
Retained Earnings		 -490 -509 -532 -552 -583 -597 -616 -615 -627
Accumulated Other Comprehensive Income / (Loss)		 - -0.02 -0.02 0.13 0.01 -0.00 0.01 -0.01 -0.01

Annual Metrics And Ratios for Codexis

This table displays calculated financial ratios and metrics derived from Codexis' official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 10.60% 18.40% 16.82% 2.43% 21.13% 12.98% 0.87% 51.69% 32.30% -49.39% -15.39%
EBITDA Growth		 59.20% 80.02% -62.59% -435.51% 52.59% 17.16% -125.74% 20.08% -88.15% -154.90% 13.85%
EBIT Growth		 53.33% 58.97% -9.07% -166.37% 49.76% -13.97% -82.32% 10.50% -61.29% -131.16% 14.23%
NOPAT Growth		 53.55% 59.34% -10.22% -168.22% 50.83% -11.10% -90.61% 5.11% -53.68% -95.15% 14.03%
Net Income Growth		 53.83% 60.25% -12.89% -168.71% 52.70% -9.72% -101.17% 11.37% -57.86% -126.96% 14.38%
EPS Growth		 53.70% 62.00% -10.53% -138.10% 58.00% 0.00% -90.48% 17.50% -54.55% -119.61% 20.54%
Operating Cash Flow Growth		 101.40% -234.89% -329.56% -370.70% -60.98% 10.88% -31.08% 13.34% 179.09% -566.48% 6.13%
Free Cash Flow Firm Growth		 93.61% -341.18% -38.68% -116.02% -49.32% -162.87% -68.19% 65.81% 118.28% -164.35% -1,768.50%
Invested Capital Growth		 -98.74% -987.50% -45.28% -219.00% 142.17% 1,318.70% 151.33% 10.31% -26.74% -55.75% 46.26%
Revenue Q/Q Growth		 15.23% -5.86% -3.21% 30.71% -8.53% 3.92% 33.56% -9.89% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 40.81% -511.22% -922.89% 21.55% -16.68% 6.49% -18.09% -55.43% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 33.86% -60.04% -54.41% 21.11% -15.79% -2.11% -14.07% -40.40% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 34.66% -56.65% -54.39% 21.06% -15.59% -2.47% 33.39% -1,692.81% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 34.75% -46.27% -59.93% 21.32% -15.15% -1.48% -15.85% -41.77% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 35.06% -35.71% -61.54% 21.88% -10.53% -5.00% -14.29% -37.50% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 103.75% 83.44% -1,498.50% 21.96% -145.20% -30.57% 11.64% 13.11% 0.00% -43.49% 0.00%
Free Cash Flow Firm Q/Q Growth		 74.59% 34.11% -2.29% -9.29% -55.32% -0.16% -174.18% 50.17% 115.26% 0.00% 0.00%
Invested Capital Q/Q Growth		 -91.77% -132.81% -136.34% -59.97% 1,634.38% 6.71% 149.92% 19.86% -34.62% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 72.45% 84.25% 80.03% 71.36% 79.17% 77.17% 80.10% 78.80% 72.56% 81.74% 72.55%
EBITDA Margin		 -35.85% -6.05% -8.42% -44.02% -17.23% -12.63% -28.27% -14.89% -21.18% -106.67% -108.62%
Operating Margin		 -54.13% -18.59% -17.54% -45.92% -18.64% -18.33% -34.64% -21.67% -25.17% -97.04% -98.61%
EBIT Margin		 -54.79% -18.99% -17.73% -46.10% -19.12% -19.29% -34.86% -20.57% -25.08% -114.54% -116.12%
Profit (Net Income) Margin		 -54.01% -18.13% -17.52% -45.97% -17.95% -17.43% -34.77% -20.31% -24.24% -108.69% -109.99%
Tax Burden Percent		 98.68% 95.73% 99.53% 100.35% 99.66% 100.14% 101.43% 100.90% 100.83% 100.09% 100.05%
Interest Burden Percent		 99.91% 99.76% 99.31% 99.36% 94.21% 90.25% 98.32% 97.87% 95.85% 94.81% 94.67%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -208.65% 0.00% 0.00% 0.00% 0.00% -41.69% -24.21% -15.27% -25.82% -82.62% -94.02%
ROIC Less NNEP Spread (ROIC-NNEP)		 -187.94% 0.00% 0.00% 0.00% 0.00% -36.42% -13.63% -6.74% -10.54% -33.35% -20.80%
Return on Net Nonoperating Assets (RNNOA)		 152.39% 0.00% 0.00% 0.00% 0.00% 26.94% 6.79% 2.55% 4.09% 16.73% 8.99%
Return on Equity (ROE)		 -56.26% -30.82% -40.77% -105.38% -26.91% -14.75% -17.42% -12.72% -21.73% -65.89% -85.03%
Cash Return on Invested Capital (CROIC)		 -13.64% 0.00% 0.00% 0.00% -622.07% -215.35% -110.36% -25.08% 5.04% -5.32% -131.59%
Operating Return on Assets (OROA)		 -36.17% -17.11% -21.57% -51.67% -17.43% -11.57% -12.99% -9.21% -13.99% -41.53% -48.26%
Return on Assets (ROA)		 -35.66% -16.34% -21.32% -51.52% -16.37% -10.45% -12.95% -9.09% -13.52% -39.41% -45.72%
Return on Common Equity (ROCE)		 -56.26% -30.82% -40.77% -105.38% -26.91% -14.75% -17.42% -12.72% -21.73% -65.89% -85.03%
Return on Equity Simple (ROE_SIMPLE)		 -72.48% -33.14% -44.81% -93.68% -19.32% -11.31% -14.12% -12.94% -23.20% -88.02% -97.53%
Net Operating Profit after Tax (NOPAT)		 -13 -5.44 -5.99 -16 -7.91 -8.78 -17 -16 -24 -48 -41
NOPAT Margin		 -37.89% -13.01% -12.28% -32.14% -13.05% -12.83% -24.25% -15.17% -17.62% -67.93% -69.03%
Net Nonoperating Expense Percent (NNEP)		 -20.71% -8.49% -11.28% -26.46% -7.02% -5.27% -10.58% -8.53% -15.28% -49.27% -73.22%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -13.33% -46.42% -32.30%
Cost of Revenue to Revenue		 27.55% 15.75% 19.97% 28.64% 20.83% 22.83% 19.90% 21.20% 27.44% 18.26% 27.45%
SG&A Expenses to Revenue		 62.13% 53.38% 52.05% 57.99% 48.34% 46.02% 50.75% 47.08% 37.64% 75.92% 92.93%
R&D to Revenue		 64.45% 49.45% 45.52% 59.29% 49.47% 49.48% 63.98% 53.38% 57.80% 83.95% 77.96%
Operating Expenses to Revenue		 126.58% 102.83% 97.57% 117.28% 97.81% 95.50% 114.74% 100.47% 97.73% 178.78% 171.16%
Earnings before Interest and Taxes (EBIT)		 -19 -7.94 -8.66 -23 -12 -13 -24 -22 -35 -80 -69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -13 -2.53 -4.11 -22 -10 -8.65 -20 -16 -29 -75 -64
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.66 7.29 9.79 15.73 15.48 8.57 7.62 12.28 2.10 2.40 5.23
Price to Tangible Book Value (P/TBV)		 5.70 9.91 11.76 18.12 16.43 8.84 7.77 12.53 2.15 2.47 5.43
Price to Revenue (P/Rev)		 2.73 3.99 3.83 7.72 14.39 13.20 18.76 19.27 2.20 2.96 5.90
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 438.35 0.00 0.00 0.00 294.88 21.28 11.78 17.43 2.60 4.47 6.49
Enterprise Value to Revenue (EV/Rev)		 1.99 3.41 3.39 7.09 13.50 12.24 16.89 18.16 1.50 2.26 5.66
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 218.49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 18.43 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 43.61 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.07 0.06 0.05 0.03 0.00 0.24 0.13 0.00 0.27 0.19 0.89
Long-Term Debt to Equity		 0.07 0.06 0.05 0.03 0.00 0.24 0.13 0.00 0.27 0.14 0.85
Financial Leverage		 -0.81 -1.03 -1.08 -1.20 -1.05 -0.74 -0.50 -0.38 -0.39 -0.50 -0.43
Leverage Ratio		 1.58 1.89 1.91 2.05 1.64 1.41 1.35 1.40 1.61 1.67 1.86
Compound Leverage Factor		 1.58 1.88 1.90 2.03 1.55 1.27 1.32 1.37 1.54 1.59 1.76
Debt to Total Capital		 6.19% 5.42% 4.43% 3.01% 0.17% 19.18% 11.64% 0.00% 20.98% 15.61% 47.23%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.05% 0.00% 0.00% 0.00% 3.68% 2.23%
Long-Term Debt to Total Capital		 6.19% 5.42% 4.43% 3.01% 0.17% 19.14% 11.64% 0.00% 20.98% 11.93% 45.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 93.81% 94.58% 95.57% 96.99% 99.83% 80.82% 88.36% 100.00% 79.02% 84.39% 52.77%
Debt to EBITDA		 -0.14 -0.52 -0.22 -0.03 -0.01 -2.90 -1.15 0.00 -1.31 -0.21 -0.93
Net Debt to EBITDA		 2.07 9.61 5.14 1.41 5.13 7.65 6.65 0.00 3.29 0.66 0.22
Long-Term Debt to EBITDA		 -0.14 -0.52 -0.22 -0.03 -0.01 -2.89 -1.15 0.00 -1.31 -0.16 -0.89
Debt to NOPAT		 -0.13 -0.24 -0.15 -0.05 -0.01 -2.85 -1.34 0.00 -1.57 -0.34 -1.46
Net Debt to NOPAT		 1.95 4.47 3.52 1.93 6.77 7.53 7.75 0.00 3.96 1.04 0.34
Long-Term Debt to NOPAT		 -0.13 -0.24 -0.15 -0.05 -0.01 -2.84 -1.34 0.00 -1.57 -0.26 -1.39
Altman Z-Score		 -5.49 -3.46 -3.63 -0.30 17.97 10.20 13.59 13.33 0.02 -3.53 -3.25
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.40 2.21 2.20 1.81 3.77 7.42 7.38 4.85 3.32 2.61 4.18
Quick Ratio		 2.21 2.06 2.03 1.72 3.67 8.50 8.36 5.77 3.81 2.63 4.02
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -0.87 -3.86 -5.35 -12 -17 -45 -76 -26 4.77 -3.07 -57
Operating Cash Flow to CapEx		 237.78% -36.66% -219.86% -890.64% -509.54% -337.00% -439.27% -103.44% 136.31% -1,435.45% -1,171.41%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.66 0.90 1.22 1.12 0.91 0.60 0.37 0.45 0.56 0.36 0.42
Accounts Receivable Turnover		 7.61 7.47 7.37 5.64 4.80 4.07 2.79 3.11 3.96 3.42 9.98
Inventory Turnover		 6.75 5.52 10.74 15.40 15.53 32.57 20.59 20.91 23.85 5.43 7.26
Fixed Asset Turnover		 5.68 11.77 18.56 20.13 16.00 12.40 8.66 6.75 6.31 3.68 4.00
Accounts Payable Turnover		 2.25 1.63 2.56 3.68 3.83 5.51 4.92 7.45 12.19 2.79 3.71
Days Sales Outstanding (DSO)		 47.98 48.89 49.53 64.66 76.10 89.72 130.95 117.48 92.14 106.79 36.57
Days Inventory Outstanding (DIO)		 54.08 66.14 34.00 23.71 23.50 11.21 17.73 17.45 15.30 67.16 50.24
Days Payable Outstanding (DPO)		 162.01 223.68 142.79 99.06 95.37 66.21 74.25 49.02 29.95 130.98 98.43
Cash Conversion Cycle (CCC)		 -59.95 -108.64 -59.27 -10.70 4.23 34.72 74.43 85.91 77.50 42.98 -11.62
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.16 -1.42 -2.06 -6.58 2.78 39 99 109 80 35 52
Invested Capital Turnover		 5.51 -66.36 -28.04 -11.57 -31.84 3.25 1.00 1.01 1.47 1.22 1.36
Increase / (Decrease) in Invested Capital		 -13 -1.58 -0.64 -4.52 9.36 37 60 10 -29 -45 16
Enterprise Value (EV)		 70 143 166 355 818 838 1,166 1,902 208 158 336
Market Capitalization		 96 167 187 386 872 904 1,296 2,019 305 208 350
Book Value per Share		 $0.67 $0.57 $0.46 $0.51 $1.04 $1.80 $2.87 $2.53 $2.20 $1.24 $0.82
Tangible Book Value per Share		 $0.43 $0.42 $0.39 $0.44 $0.98 $1.75 $2.81 $2.48 $2.16 $1.21 $0.79
Total Capital		 28 24 20 25 56 131 193 164 183 103 127
Total Debt		 1.74 1.31 0.89 0.76 0.10 25 22 0.00 38 16 60
Total Long-Term Debt		 1.74 1.31 0.89 0.76 0.10 25 22 0.00 38 12 57
Net Debt		 -26 -24 -21 -31 -54 -66 -130 -117 -97 -50 -14
Capital Expenditures (CapEx)		 0.14 1.18 0.85 0.98 2.77 3.73 3.75 14 8.28 3.67 4.22
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -7.22 -5.28 -4.38 -11 -2.95 7.72 8.69 12 -0.68 -4.22 3.99
Debt-free Net Working Capital (DFNWC)		 19 18 15 20 50 99 159 129 114 61 78
Net Working Capital (NWC)		 19 18 15 20 50 99 159 129 114 58 75
Net Nonoperating Expense (NNE)		 5.69 2.14 2.56 6.92 2.97 3.15 7.27 5.39 9.18 29 24
Net Nonoperating Obligations (NNO)		 -26 -24 -21 -31 -54 -66 -71 -55 -65 -51 -15
Total Depreciation and Amortization (D&A)		 6.69 5.41 4.55 1.04 1.15 4.56 4.55 5.95 5.40 5.52 4.45
Debt-free, Cash-free Net Working Capital to Revenue		 -20.44% -12.62% -8.97% -22.22% -4.88% 11.27% 12.58% 11.19% -0.49% -6.01% 6.72%
Debt-free Net Working Capital to Revenue		 54.58% 43.05% 30.43% 40.15% 82.66% 144.43% 230.89% 122.68% 82.13% 87.56% 131.35%
Net Working Capital to Revenue		 54.58% 43.05% 30.43% 40.15% 82.66% 144.35% 230.89% 122.68% 82.13% 82.17% 126.59%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.50) ($0.19) ($0.21) ($0.50) ($0.21) ($0.21) ($0.40) ($0.33) ($0.51) ($1.12) ($0.89)
Adjusted Weighted Average Basic Shares Outstanding		 39.70M 40.47M 41.38M 48.43M 54.16M 58.90M 64.40M 64.57M 65.34M 68.13M 73.41M
Adjusted Diluted Earnings per Share		 ($0.50) ($0.19) ($0.21) ($0.50) ($0.21) ($0.21) ($0.40) ($0.33) ($0.51) ($1.12) ($0.89)
Adjusted Weighted Average Diluted Shares Outstanding		 39.70M 40.47M 41.38M 48.43M 54.16M 58.90M 64.40M 64.57M 65.34M 68.13M 73.41M
Adjusted Basic & Diluted Earnings per Share		 ($0.50) ($0.19) ($0.21) ($0.50) ($0.21) ($0.21) ($0.40) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 38.21M 39.44M 40.63M 46.23M 52.21M 56.53M 59.36M 65.16M 65.95M 70.30M 82.84M
Normalized Net Operating Profit after Tax (NOPAT)		 -13 -5.44 -5.99 -16 -7.91 -8.78 -17 -16 -22 -38 -41
Normalized NOPAT Margin		 -37.89% -13.01% -12.28% -32.14% -13.05% -12.83% -24.25% -15.17% -16.02% -54.69% -68.83%
Pre Tax Income Margin		 -54.74% -18.94% -17.61% -45.81% -18.01% -17.41% -34.28% -20.13% -24.04% -108.59% -109.94%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% -2.40% -1.65% -1.03% -22.69% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Codexis

This table displays calculated financial ratios and metrics derived from Codexis' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 69,803,994.00 69,830,199.00 70,303,639.00 70,557,577.00 70,927,377.00 - 82,837,311.00 82,844,849.00 90,267,464.00 90,324,383.00 90,896,567.00
DEI Adjusted Shares Outstanding		 69,803,994.00 69,830,199.00 70,303,639.00 70,557,577.00 70,927,377.00 - 82,837,311.00 82,844,849.00 90,267,464.00 90,324,383.00 90,896,567.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.50 -0.10 -0.16 -0.32 -0.29 - -0.25 -0.16 -0.22 -0.10 -0.13
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -73.09% -12.55% 31.51% -62.58% 38.33% -19.20% -55.82% 92.10% -32.98% 102.15% -2.69%
EBITDA Growth		 -360.78% 55.69% 53.10% -79.15% 42.95% -48.97% -82.54% 44.86% 8.05% 61.00% 10.62%
EBIT Growth		 -245.06% 39.27% 47.64% -87.71% 40.26% -40.30% -72.75% 41.62% 5.76% 56.44% 9.50%
NOPAT Growth		 -201.43% 102.13% 49.77% -80.04% 48.36% -2,703.55% -72.33% 43.42% -14.45% 60.74% 12.70%
Net Income Growth		 -249.36% 42.94% 49.13% -97.47% 40.87% -44.27% -79.82% 41.67% 4.97% 57.93% 9.55%
EPS Growth		 -233.33% 42.11% 52.94% -88.24% 42.00% -9.09% -56.25% 50.00% 24.14% 60.00% 18.75%
Operating Cash Flow Growth		 0.00% -324.47% 15.45% 0.00% 0.00% -49.21% -77.15% -47.66% 40.68% 4.70% 46.33%
Free Cash Flow Firm Growth		 358.13% 124.90% -98.65% -82.61% -132.72% -148.03% -4,496.33% -304.92% -16.05% 85.57% 105.09%
Invested Capital Growth		 0.00% -55.75% -22.50% -60.39% 0.00% 46.26% 55.37% 138.24% 116.94% -2.22% -17.58%
Revenue Q/Q Growth		 0.00% 186.31% -35.72% -53.27% 60.83% 67.23% -64.85% 103.21% -43.89% 0.00% -2.18%
EBITDA Q/Q Growth		 0.00% 80.96% -62.28% -103.73% 9.37% 52.51% -98.84% 38.46% -51.11% 0.00% -41.07%
EBIT Q/Q Growth		 0.00% 77.57% -53.84% -91.20% 9.44% 47.33% -89.43% 35.38% -46.19% 0.00% -34.25%
NOPAT Q/Q Growth		 0.00% 100.88% -4,315.60% -91.22% 27.16% 55.66% -179.02% 37.22% -47.33% 0.00% -39.61%
Net Income Q/Q Growth		 0.00% 79.40% -59.97% -97.78% 9.29% 49.73% -99.38% 35.85% -47.79% 0.00% -37.93%
EPS Q/Q Growth		 0.00% 78.00% -45.45% -100.00% 9.38% 58.62% -108.33% 36.00% -37.50% 0.00% -30.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 29.43% -56.22% -6.71% 0.00% 16.21% -30.21% 57.13% 0.00% 26.67%
Free Cash Flow Firm Q/Q Growth		 0.00% -55.16% -98.40% 2,754.34% -259.35% 34.18% -46.85% -33.05% 9.76% 0.00% 146.98%
Invested Capital Q/Q Growth		 0.00% 0.00% -11.98% -23.31% -11.72% 145.44% -6.50% 17.60% -19.61% 0.00% -0.88%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 75.76% 89.23% 71.56% 56.61% 66.36% 82.97% 63.78% 86.31% 71.34% 86.46% 76.45%
EBITDA Margin		 -387.57% -25.78% -65.08% -283.69% -159.85% -47.53% -268.89% -81.43% -219.30% -51.87% -74.80%
Operating Margin		 -345.59% 1.06% -69.63% -284.90% -129.02% -34.21% -271.59% -83.91% -220.31% -52.75% -75.29%
EBIT Margin		 -387.57% -30.36% -72.65% -297.24% -167.37% -52.71% -284.08% -90.33% -235.33% -61.21% -84.01%
Profit (Net Income) Margin		 -376.29% -27.08% -67.39% -285.19% -160.84% -48.35% -274.27% -86.59% -228.05% -57.08% -80.49%
Tax Burden Percent		 100.03% 100.49% 100.09% 100.04% 100.05% 100.04% 100.05% 100.08% 100.04% 100.42% 100.08%
Interest Burden Percent		 97.06% 88.76% 92.67% 95.90% 96.05% 91.69% 96.50% 95.78% 96.87% 92.87% 95.73%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.90% -101.45% -288.49% -552.08% -32.62% -238.16% -83.13% -244.31% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 13.64% -96.70% -274.99% -517.48% -16.85% -212.44% -59.60% -216.16% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -6.84% 63.10% 150.24% 164.17% 7.29% 81.36% 18.48% 87.12% 0.00% 0.00%
Return on Equity (ROE)		 0.00% -5.94% -38.35% -138.24% -387.92% -25.33% -156.80% -64.65% -157.19% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 0.00% -5.32% -85.14% -23.90% 0.00% -131.59% -161.51% -180.95% -198.73% 2.24% 19.27%
Operating Return on Assets (OROA)		 0.00% -11.01% -29.34% -106.85% -71.28% -21.91% -101.65% -38.21% -91.54% 0.00% 0.00%
Return on Assets (ROA)		 0.00% -9.82% -27.21% -102.52% -68.50% -20.10% -98.13% -36.63% -88.71% 0.00% 0.00%
Return on Common Equity (ROCE)		 0.00% -5.94% -38.35% -138.24% -387.92% -25.33% -156.80% -64.65% -157.19% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% -82.16% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -22 0.20 -8.32 -16 -12 -5.14 -14 -9.00 -13 -5.63 -7.86
NOPAT Margin		 -241.91% 0.74% -48.74% -199.43% -90.31% -23.95% -190.11% -58.74% -154.22% -36.92% -52.70%
Net Nonoperating Expense Percent (NNEP)		 0.00% -12.73% -4.75% -13.50% -34.60% -15.77% -25.72% -23.52% -28.15% 216.62% 54.49%
Return On Investment Capital (ROIC_SIMPLE)		 - 0.19% -6.79% -15.29% -10.05% -4.05% -13.14% -7.23% -12.38% -4.85% -7.44%
Cost of Revenue to Revenue		 24.24% 10.77% 28.44% 43.39% 33.64% 17.03% 36.22% 13.69% 28.66% 13.54% 23.55%
SG&A Expenses to Revenue		 132.61% 45.87% 75.32% 196.40% 105.73% 60.81% 163.79% 80.36% 130.42% 64.13% 73.26%
R&D to Revenue		 147.27% 42.30% 65.87% 143.04% 89.65% 56.38% 171.58% 89.87% 161.24% 75.08% 78.48%
Operating Expenses to Revenue		 421.34% 88.17% 141.19% 341.51% 195.38% 117.19% 335.37% 170.22% 291.65% 139.21% 151.74%
Earnings before Interest and Taxes (EBIT)		 -36 -8.06 -12 -24 -21 -11 -21 -14 -20 -9.33 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -36 -6.85 -11 -23 -21 -10 -20 -12 -19 -7.91 -11
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 2.40 3.08 3.55 3.02 5.23 4.47 3.75 5.71 3.42 6.24
Price to Tangible Book Value (P/TBV)		 0.00 2.47 3.17 3.70 3.13 5.43 4.70 3.92 6.10 3.63 6.75
Price to Revenue (P/Rev)		 0.00 2.96 3.28 3.58 3.44 5.90 4.45 3.64 4.16 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 4.47 6.14 7.43 7.93 6.49 4.57 3.70 5.02 3.23 4.70
Enterprise Value to Revenue (EV/Rev)		 0.00 2.26 2.58 2.91 2.59 5.66 4.43 3.68 4.34 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 142.44 22.06
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.19 0.55 0.69 0.57 0.89 1.20 1.24 1.78 1.69 2.20
Long-Term Debt to Equity		 0.00 0.14 0.50 0.63 0.52 0.85 1.14 1.19 1.70 1.61 1.89
Financial Leverage		 0.00 -0.50 -0.65 -0.55 -0.32 -0.43 -0.38 -0.31 -0.40 0.03 0.17
Leverage Ratio		 0.00 1.67 1.79 1.83 1.84 1.86 2.16 2.31 2.43 2.78 2.92
Compound Leverage Factor		 0.00 1.48 1.66 1.75 1.76 1.71 2.08 2.21 2.35 2.58 2.79
Debt to Total Capital		 0.00% 15.61% 35.32% 40.94% 36.35% 47.23% 54.52% 55.36% 64.03% 62.79% 68.79%
Short-Term Debt to Total Capital		 0.00% 3.68% 3.17% 3.82% 3.54% 2.23% 2.67% 2.41% 2.88% 2.84% 9.80%
Long-Term Debt to Total Capital		 0.00% 11.93% 32.15% 37.12% 32.81% 45.00% 51.85% 52.95% 61.15% 59.94% 58.98%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 84.39% 64.68% 59.06% 63.65% 52.77% 45.48% 44.64% 35.97% 37.21% 31.21%
Debt to EBITDA		 0.00 -0.21 -0.68 -0.57 -0.69 -0.93 -0.81 -1.09 -1.11 0.00 0.00
Net Debt to EBITDA		 0.00 0.66 0.82 0.54 0.89 0.22 0.01 -0.03 -0.15 0.00 0.00
Long-Term Debt to EBITDA		 0.00 -0.16 -0.62 -0.51 -0.62 -0.89 -0.77 -1.04 -1.06 0.00 0.00
Debt to NOPAT		 0.00 -0.34 -1.10 -0.92 -1.18 -1.46 -1.27 -1.72 -1.64 0.00 0.00
Net Debt to NOPAT		 0.00 1.04 1.33 0.88 1.53 0.34 0.02 -0.05 -0.23 0.00 0.00
Long-Term Debt to NOPAT		 0.00 -0.26 -1.00 -0.83 -1.06 -1.39 -1.20 -1.65 -1.57 0.00 0.00
Altman Z-Score		 0.00 -1.78 -1.83 -3.36 -2.85 -1.98 -4.29 -3.81 -4.97 -5.27 -5.76
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 2.61 3.71 2.99 3.21 4.18 3.72 5.82 4.12 5.36 3.06
Quick Ratio		 0.00 2.63 3.62 2.95 3.14 4.02 3.58 5.63 3.79 4.98 2.87
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 100 45 0.72 21 -33 -22 -32 -42 -38 -4.56 2.14
Operating Cash Flow to CapEx		 0.00% 0.00% -696.07% -3,112.02% -1,385.81% -929.87% -1,099.44% -715.82% -4,255.80% -7,471.59% -1,073.83%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.36 0.40 0.36 0.43 0.42 0.36 0.42 0.39 0.00 0.00
Accounts Receivable Turnover		 0.00 3.42 5.79 8.08 14.13 9.98 11.24 15.53 20.83 0.00 0.00
Inventory Turnover		 0.00 5.43 5.92 6.27 7.03 7.26 6.71 6.13 5.42 0.00 0.00
Fixed Asset Turnover		 0.00 3.68 3.88 3.27 4.51 4.00 3.27 3.95 3.88 0.00 0.00
Accounts Payable Turnover		 0.00 2.79 3.30 3.48 4.24 3.71 2.98 4.97 3.30 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 106.79 63.03 45.17 25.83 36.57 32.48 23.50 17.52 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 67.16 61.61 58.23 51.92 50.24 54.40 59.55 67.32 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 130.98 110.52 105.03 86.10 98.43 122.54 73.46 110.63 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 42.98 14.13 -1.63 -8.35 -11.62 -35.67 9.59 -25.78 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 35 31 24 21 52 48 57 46 47 47
Invested Capital Turnover		 0.00 1.22 2.08 1.45 6.11 1.36 1.25 1.42 1.58 0.00 0.00
Increase / (Decrease) in Invested Capital		 -122 -45 -9.04 -36 21 16 17 33 25 -1.07 -10
Enterprise Value (EV)		 0.00 158 191 177 167 336 221 210 230 153 221
Market Capitalization		 131 208 244 218 222 350 222 208 220 148 206
Book Value per Share		 $0.00 $1.24 $1.13 $0.87 $1.03 $0.82 $0.60 $0.67 $0.43 $0.48 $0.36
Tangible Book Value per Share		 $0.00 $1.21 $1.09 $0.84 $1.00 $0.79 $0.57 $0.64 $0.40 $0.45 $0.34
Total Capital		 0.00 103 123 104 115 127 109 125 107 116 106
Total Debt		 0.00 16 43 43 42 60 59 69 69 73 73
Total Long-Term Debt		 0.00 12 39 39 38 57 57 66 66 70 62
Net Debt		 0.00 -50 -52 -41 -55 -14 -0.79 2.15 9.44 4.88 15
Capital Expenditures (CapEx)		 0.00 -1.10 1.12 0.39 0.94 1.77 1.26 2.51 0.18 0.18 0.90
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -4.22 -3.29 -8.88 -8.92 3.99 -0.47 9.66 1.62 2.54 3.42
Debt-free Net Working Capital (DFNWC)		 0.00 61 83 65 82 78 60 76 61 68 59
Net Working Capital (NWC)		 0.00 58 79 61 78 75 57 73 58 65 48
Net Nonoperating Expense (NNE)		 12 7.39 3.18 6.84 9.05 5.24 6.35 4.27 6.35 3.07 4.14
Net Nonoperating Obligations (NNO)		 0.00 -51 -48 -38 -52 -15 -1.24 1.27 7.20 4.08 14
Total Depreciation and Amortization (D&A)		 0.00 1.22 1.29 1.08 0.97 1.11 1.15 1.36 1.38 1.42 1.37
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -6.01% -4.43% -14.58% -13.83% 6.72% -0.93% 16.90% 3.06% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 87.56% 111.47% 106.48% 127.01% 131.35% 120.08% 133.81% 114.88% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 82.17% 106.24% 99.95% 120.68% 126.59% 114.24% 128.56% 109.04% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.11) ($0.16) ($0.32) ($0.29) ($0.12) ($0.25) ($0.16) ($0.22) ($0.10) ($0.13)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 68.13M 69.85M 70.38M 72.03M 73.41M 82.41M 85.39M 90.25M 90.77M 91.05M
Adjusted Diluted Earnings per Share		 $0.00 ($0.11) ($0.16) ($0.32) ($0.29) ($0.12) ($0.25) ($0.16) ($0.22) ($0.10) ($0.13)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 68.13M 69.85M 70.38M 72.03M 73.41M 82.41M 85.39M 90.25M 90.77M 91.05M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 70.30M 70.56M 70.93M 81.38M 82.84M 82.84M 90.27M 90.32M 90.90M 109.51M
Normalized Net Operating Profit after Tax (NOPAT)		 -13 0.20 -8.32 -16 -12 -5.14 -14 -9.00 -13 -5.63 -7.86
Normalized NOPAT Margin		 -142.88% 0.74% -48.74% -197.98% -90.31% -23.95% -190.11% -58.74% -154.22% -36.92% -52.70%
Pre Tax Income Margin		 -376.19% -26.95% -67.33% -285.06% -160.76% -48.33% -274.12% -86.52% -227.96% -56.85% -80.42%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Codexis’ financial results show improving revenue from the 2024 lows, but the company remains unprofitable and continues to consume cash. Revenue reached $14.9 million in Q2 2026, up from $8.6 million in Q3 2025 and $8.0 million in Q2 2024, although it was slightly below $15.3 million in Q1 2026 and Q2 2025. The longer-term recovery is encouraging, but quarterly revenue remains uneven.

Gross profitability has generally improved from 2024 levels, supported by lower cost of revenue. However, Q2 2026 gross margin fell to approximately 76%, compared with roughly 86% in Q1 2026 and Q2 2025. Operating expenses of $22.6 million exceeded gross profit of $11.4 million, producing an operating loss of $11.2 million. The operating loss was narrower than the $20.5 million loss in Q2 2024, but wider than the $8.0 million loss in Q1 2026.

Codexis reported a Q2 2026 net loss of $12.0 million, or $0.13 per diluted share. Losses have narrowed substantially from $22.8 million in Q2 2024 and $20.6 million in Q3 2024, but the company has not yet demonstrated a path to sustained profitability. Research and development spending remains significant at $11.7 million for the quarter, while selling, general and administrative expense increased to $10.9 million.

Liquidity remains a meaningful offset to the operating losses. At June 30, 2026, Codexis held $27.2 million in cash, $27.7 million in short-term investments and $2.5 million in long-term investments. Including restricted cash and the note and lease receivable, the company had substantial financial assets. Nevertheless, cash and equivalents declined by $9.4 million during Q2, and operating activities consumed $9.6 million of cash.

  • Revenue has recovered from the very low quarterly levels seen in 2024 and Q3 2025, with Q2 2026 revenue of $14.9 million.
  • Gross margin remains considerably better than the roughly 57% margin reported in Q2 2024, indicating improved economics compared with the earlier period.
  • Net losses have narrowed compared with 2024, declining from more than $20 million in several 2024 quarters to $12.0 million in Q2 2026.
  • Codexis retains meaningful liquidity, including approximately $55.3 million of cash, restricted cash and short-term investments at the end of Q2 2026, before considering other investments and receivables.
  • Investment purchases and maturities continue to be a major source of cash-flow volatility. Q2 investing cash flow was slightly positive because $14.0 million of investments matured or were sold against $12.9 million of purchases.
  • The current ratio was approximately 3.1 at June 30, 2026, still indicating current assets above current liabilities, but down considerably from approximately 5.4 at March 31, 2026.
  • Operating cash flow remained negative at $9.6 million in Q2 2026, following negative operating cash flow of $13.2 million in Q1 2026 and $18.0 million in Q2 2025.
  • Codexis continues to report operating and net losses, with Q2 operating expenses of $22.6 million exceeding gross profit by nearly $11.2 million.
  • Total debt and capital lease obligations were approximately $72.6 million at quarter-end, while cash declined to $27.2 million from $36.6 million in Q1 2026.
  • Shareholder equity fell to $33.0 million in Q2 2026 from $55.6 million in Q2 2025, and weighted-average basic shares increased to 91.1 million from 69.9 million in Q1 2024, indicating cumulative losses and potential dilution pressure.

Overall, Codexis’ trend is mixed. Revenue and gross profitability are better than during the 2024 downturn, and losses have moderated. However, Q2 2026 showed sequential deterioration in revenue, gross margin and operating income, while persistent cash burn, sizable debt obligations and declining equity remain important risks for investors.

10/09/26 05:46 AM ETAI Generated. May Contain Errors.

Codexis Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Codexis' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

Codexis' net income appears to be on a downward trend, with a most recent value of -$65.28 million in 2024, falling from -$19.07 million in 2014. The previous period was -$76.24 million in 2023. Find out what analysts predict for Codexis in the coming months.

Codexis' total operating income in 2024 was -$58.52 million, based on the following breakdown:
  • Total Gross Profit: $43.06 million
  • Total Operating Expenses: $101.58 million

Over the last 10 years, Codexis' total revenue changed from $35.31 million in 2014 to $59.35 million in 2024, a change of 68.1%.

In the past 11 quarters, Codexis' cash and equivalents has ranged from $18.32 million in Q1 2025 to $74.58 million in Q3 2023, and is currently $27.17 million as of their latest financial filing in Q2 2026.

Codexis had total debt of $59.90 million at the end of 2024, a 273.8% increase from 2023, and a 3,352.2% increase since 2014.

Over the last 10 years, Codexis' book value per share changed from 0.67 in 2014 to 0.82 in 2024, a change of 23.6%.


Related Companies

Financial statements for NASDAQ:CDXS last updated on 8/11/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel